TOP25 728X90
SEARCH RESULTS FOR: "Tag: hims"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2026(1)
2025(13)
2024(9)
CATEGORIES
5-Minute Market Rundown(1)
Bernie's Content(1)
Buzz Stocks(11)
Earnings Preview(2)
Editor's Pick(2)
Intraday Option Activity(5)
Investor Sentiment(1)
Most Active Options Update(2)
Options Recommendations(4)
Quantitative Analysis(3)
Stocks On the Move(1)
Technical Analysis(2)
Trade Postmortem(1)
Trader Content(1)

1/26/2026 3:16 PM
Hims & Hers Health Inc (NYSE:HIMS) shares are up 3.4% to trade at $30.60 at last glance. The equity has struggled of late, now carrying a 47.3% nine-month deficit after last week gapping to its lowes...
10/24/2025 12:35 PM
All three major benchmarks are on their way to weekly wins, but it was far from the smooth sailing investors have gotten accustomed to. This week was rife with choppy price action, as investors wr...
10/23/2025 12:14 PM
Telehealth stock Hims & Hers Health Inc (NYSE:HIMS) just suffered a steep pullback after President Donald Trump's said Novo Nordisk's (NVO) weight-loss and diabetes drugs, Wegovy and Ozempic,...
9/19/2025 10:19 AM
Subscribers to Schaeffer's Weekend Trader options recommendation service received this HIMS commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry a...
6/23/2025 10:55 AM
Novo Nordisk A/S (NYSE:NVO) stock is down 5.3% to trade at $69.90 at last check, after the drugmaker's obesity drug CagriSema showed no clear advantage over Eli Lilly's (LLY) Zepbound. The company a...